EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Allocation of authorship and patient enrollment among global clinical trials in oncology

Fidel Rubagumya iD, Adam Fundytus, Sophie Keith-Brown, Wilma M Hopman, Bishal Gyawali, Deborah Mukherji, Nazik Hammad, C S Pramesh, Ajay Aggarwal, Alexandru Eniu iD, Manju Sengar, Rachel S R Riechelmann und 2 weitere

Cancer · 15.09.2023 · 129 (18) · 2856-2863

DOI: 10.1002/cncr.34919 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 29.06.2023. Verfasst von Fidel Rubagumya und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada. Hauptthemen laut MEDLINE: Authorship, Developing Countries. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oncology randomized controlled trials (RCTs) are increasingly global in scope. Whether authorship is equitably shared between investigators from high‐income countries (HIC) and low‐middle/upper‐middle incomes countries (LMIC/UMIC) is not well described. The authors conducted this study to understand the allocation of authorship and patient enrollment across all oncology RCTs conducted globally.

Methods

A cross‐sectional retrospective cohort study of phase 3 RCTs (published 2014–2017) that were led by investigators in HIC and recruited patients in LMIC/UMIC.

Findings

During 2014–2017, 694 oncology RCTs were published; 636 (92%) were led by investigators from HIC. Among these HIC‐led trials, 186 (29%) enrolled patients in LMIC/UMIC. One‐third (33%, 62 of 186) of RCTs had no authors from LMIC/UMIC. Forty percent (74 of 186) of RCTs reported patient enrollment by country; in 50% (37 of 74) of these trials, LMIC/UMIC contributed

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AuthorshipDeveloping CountriesHumansCross-Sectional StudiesIncomeMedical OncologyRandomized Controlled Trials as TopicClinical Trials, Phase III as Topic

Stichwörter der Autor:innen

HICsLMICsUMICsauthorshipclinical trialsglobal healthoncologypatients enrollment

Autor:innen und Institutionen

  • Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada.
  • Department of Oncology, Queen's University, Kingston, Ontario, Canada.
  • Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
  • Department of Oncology, Rwanda Military Hospital, Kigali, Rwanda.
  • British Columbia Cancer Agency, Victoria, British Columbia, Canada.
  • American University of Beirut Medical Center, Beirut, Lebanon.

ORCID-Profile: Fidel Rubagumya, Alexandru Eniu, Christopher M Booth

Zitieren

APA

Rubagumya, F., Fundytus, A., Keith-Brown, S., Hopman, W. M., Gyawali, B., Mukherji, D., Hammad, N., Pramesh, C. S., Aggarwal, A., Eniu, A., Sengar, M., Riechelmann, R. S. R., Sullivan, R., & Booth, C. M. (2023). Allocation of authorship and patient enrollment among global clinical trials in oncology. Cancer, 129(18), 2856-2863. https://doi.org/10.1002/cncr.34919

Vancouver

Rubagumya F, Fundytus A, Keith-Brown S, Hopman WM, Gyawali B, Mukherji D, et al. Allocation of authorship and patient enrollment among global clinical trials in oncology. Cancer. 2023;129(18):2856-2863. doi:10.1002/cncr.34919

BibTeX
@article{Rubagumya2023,
  author = {Rubagumya, Fidel and Fundytus, Adam and Keith-Brown, Sophie and Hopman, Wilma M and Gyawali, Bishal and Mukherji, Deborah and Hammad, Nazik and Pramesh, C S and Aggarwal, Ajay and Eniu, Alexandru and Sengar, Manju and Riechelmann, Rachel S R and Sullivan, Richard and Booth, Christopher M},
  title = {Allocation of authorship and patient enrollment among global clinical trials in oncology},
  journal = {Cancer},
  year = {2023},
  volume = {129},
  number = {18},
  pages = {2856--2863},
  doi = {10.1002/cncr.34919}
}
Kostenlos starten →